Role of the AMP kinase in cytokine-induced human EndoC-βH1 cell death

Molecular and Cellular Endocrinology

Volumn 414, Issue , 2015, Pages 53-63

  Fred, Rikard G ^a   Kappe, Camilla ^a   Ameur, Adam ^a   Cen, Jing ^a   Bergsten, Peter ^a   Ravassard, Phillippe ^b   Scharfmann, Raphael ^c   Welsh, Nils ^a  

^a SCIENCE FOR LIFE LABORATORY   (Sweden)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^c INSERM   (France)

Author keywords

AMPK; Apoptosis; ATP; Cytokines; EndoC H1 cells; NF kappaB; STAT 1

Indexed keywords

ADENYLATE KINASE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INITIATION FACTOR 2ALPHA; INTERLEUKIN 1BETA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; ADENOSINE TRIPHOSPHATE; AICA RIBONUCLEOTIDE; DACTINOMYCIN; INTERLEUKIN-1BETA (163-171); PEPTIDE FRAGMENT; RIBONUCLEOTIDE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL RESPIRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE;

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CELL DEATH; CELL LINE; CELL RESPIRATION; DACTINOMYCIN; GENE EXPRESSION REGULATION; HUMANS; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MICE; PEPTIDE FRAGMENTS; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION;

EID: 84938218839     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.07.015     Document Type: Article

References (46)

1. Allagnat F., Klee P., Cardozo A.K., Meda P., Haefliger J.A. Connexin36 contributes to INS-1E cells survival through modulation of cytokine-induced oxidative stress, ER stress and AMPK activity. Cell Death Differ. 2013, 20:1742-1752.
2. Ammendrup A., Maillard A., Nielsen K., Aabenhus Andersen N., Serup P., Dragsbaek Madsen O., Mandrup-Poulsen T., Bonny C. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 2000, 49:1468-1476.
3. Andersson L.E., Valtat B., Bagge A., Sharoyko V.V., Nicholls D.G., Ravassard P., Scharfmann R., Spégel P., Mulder H. Characterization of stimulus-secretion coupling in the human pancreatic EndoC-βH1 beta cell line. PLoS One 2015, 10:e0120879.
4. Cabrera O., Berman D.M., Kenyon N.S., Ricordi C., Berggren P.O., Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2334-2339.
5. Collier J.J., Fueger P.T., Hohmeier H.E., Newgard C.B. Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and beta-cell lines. Diabetes 2006, 55:1398-1406.
6. Corbett J.A., Sweetland M.A., Wang J.L., Lancaster J.R., McDaniel M.L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:1731-1735.
7. Delaney C.A., Pavlovic D., Hoorens A., Pipeleers D.G., Eizirik D.L. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 1997, 138:2610-2614.
8. Eizirik D.L., Flodström M., Karlsen E.A., Welsh N. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic β cells. Diabetologia 1996, 39:875-890.
9. Eizirik D.L., Mandrup-Poulsen T. Achoice of death - the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001, 44:2115-2133.
10. Eizirik D.L., Sandler S., Welsh N., Cetkovic-Cvrlje M., Nieman A., Geller D.A., Pipeleers D.G., Bendtzen K., Hellerström C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J.Clin. Investig. 1994, 93:1968-1974.
11. Frank D.A., Mahajan S., Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat. Med. 1999, 5:444-447.
12. Hindlycke H., Lu T., Welsh N. Cytokine-induced human islet cell death invitro correlates with a persistently high phosphorylation of STAT-1, but not with NF-κB activation. Biochem. Biophys. Res. Commun. 2012, 418:845-850.
13. Hägerkvist R., Sandler S., Mokhtari D., Welsh N. Amelioration of diabetes by imatinib mesylate (Gleevec): role of β-cell NF-kappaB activation and anti-apoptotic preconditioning. FASEB J. 2007, 21:618-628.
14. Krebs H.A., Henseleit K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seyler's Z. Physiol. Chem. 1932, 210:33-66.
15. Leclerc I., Woltersdorf W.W., da Silva Xavier G., Rowe R.L., Cross S.E., Korbutt G.S., Rajotte R.V., Smith R., Rutter G.A. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E1023-E1031.
16. Lund S.S., Tarnow L., Astrup A.S., Hovind P., Jacobsen P.K., Alibegovic A.C., Parving I., Pietraszek L., Frandsen M., Rossing P., Parving H.H., Vaag A.A. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study. PLoS One 2008, 3:e3363.
17. Luo P., Wang M.H. Eicosanoids, β-cell function, and diabetes. Prostagl. Other Lipid Mediat. 2011, 95:1-10.
18. Makeeva N., Roomans G.M., Myers J.W., Welsh N. Transforming growth factor-beta-activated protein kinase 1-binding protein (TAB)-1alpha, but not TAB1beta, mediates cytokine-induced p38 mitogen-activated protein kinase phosphorylation and cell death in insulin-producing cells. Endocrinology 2008, 149:302-309.
19. Malmgren S., Nicholls D.G., Taneera J., Bacos K., Koeck T., Tamaddon A., Wibom R., Groop L., Ling C., Mulder H., Sharoyko V.V. Tight coupling between glucose and mitochondrial metabolism in clonal beta-cells is required for robust insulin secretion. J.Biol. Chem. 2009, 284:32395-32404.
20. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., Becker C., Franchi L., Yoshihara E., Chen Z., Mullooly N., Mielke L.A., Harris J., Coll R.C., Mills K.H., Mok K.H., Newsholme P., Nuñez G., Yodoi J., Kahn S.E., Lavelle E.C., O'Neill L.A. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 2010, 11:897-904.
21. Meares G.P., Hughes K.J., Jaimes K.F., Salvatori A.S., Rhodes C.J., Corbett J.A. AMP-activated protein kinase attenuates nitric oxide-induced beta-cell death. J.Biol. Chem. 2010, 285:3191-3200.
22. Meda P. Protein-mediated interactions of pancreatic islet cells. Scientifica (Cairo) 2013, 2013:621249.
23. Menegazzi M., Tedeschi E., Dussin D., De Prati A.C., Cavalieri E., Mariotto S., Suzuki H. Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J. 2001, 15:1309-1311.
24. Mokhtari D., Barbu A., Mehmeti I., Vercamer C., Welsh N. Overexpression of the nuclear factor-kB subunit c-Rel protects against human islet cell death invitro. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1067-E1077.
25. Moore F., Naamane N., Colli M.L., Bouckenooghe T., Ortis F., Gurzov E.N., Igoillo-Esteve M., Mathieu C., Bontempi G., Thykjaer T., Ørntoft T.F., Eizirik D.L. STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation. J.Biol. Chem. 2011, 286:929-941.
26. Nogueira T.C., Paula F.M., Villate O., Colli M.L., Moura R.F., Cunha D.A., Marselli L., Marchetti P., Cnop M., Julier C., Eizirik D.L. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet. 2013, 9:e1003532.
27. Pavlovic D., Andersen N.A., Mandrup-Poulsen T., Eizirik D.L. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells. Eur. Cytokine Netw. 2000, 11:267-274.
28. Pavlovic D., Chen M.C., Bouwens L., Eizirik D.L., Pipeleers D. Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes 1999, 48:29-33.
29. Pirot P., Cardozo A.K., Eizirik D.L. Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq. Bras. Endocrinol. Metab. 2008, 52:156-165.
30. Rabinovitch A., Suarez-Pinzon W.L., Strynadka K., Schulz R., Lakey J.R., Warnock G.L., Rajotte R.V. Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. J.Clin. Endocrinol. Metab. 1994, 79:1058-1062.
31. Ravassard P., Hazhouz Y., Pechberty S., Bricout-Neveu E., Armanet M., Czernichow P., Scharfmann R. Agenetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J.Clin. Investig. 2011, 121:3589-3597.
32. Riboulet-Chavey A., Diraison F., Siew L.K., Wong F.S., Rutter G.A. Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8+ T-cell-induced cytotoxicity. Diabetes 2008, 57:415-423.
33. Saldeen J., Lee J.C., Welsh N. Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis. Biochem. Pharmacol. 2001, 61:1561-1569.
34. Santos G.J., Oliveira C.A., Boschero A.C., Rezende L.F. CNTF protects MIN6 cells against apoptosis induced by alloxan and IL-1β through downregulation of the AMPK pathway. Cell. Signal. 2011, 23:1669-1676.
35. Sarkar S.A., Kutlu B., Velmurugan K., Kizaka-Kondoh S., Lee S.E., Wong R., Valentine A., Davidson H.W., Hutton J.C., Pugazhenthi S. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 2009, 52:1092-1101.
36. Scharfmann R., Pechberty S., Hazhouz Y., von Bülow M., Bricout-Neveu E., Grenier-Godard M., Guez F., Rachdi L., Lohmann M., Czernichow P., Ravassard P. Development of a conditionally immortalized human pancreatic β cell line. J.Clin. Investig. 2014, 124:2087-2098.
37. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Xu W., Richards D.R., McDonald-Smith G.P., Gao H., Hennessy L., Finnerty C.C., López C.M., Honari S., Moore E.E., Minei J.P., Cuschieri J., Bankey P.E., Johnson J.L., Sperry J., Nathens A.B., Billiar T.R., West M.A., Jeschke M.G., Klein M.B., Gamelli R.L., Gibran N.S., Brownstein B.H., Miller-Graziano C., Calvano S.E., Mason P.H., Cobb J.P., Rahme L.G., Lowry S.F., Maier R.V., Moldawer L.L., Herndon D.N., Davis R.W., Xiao W., Tompkins R.G. Inflammation and host response to injury, large scale collaborative research program. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3507-3512.
38. Skeldon A.M., Faraj M., Saleh M. Caspases and inflammasomes in metabolic inflammation. Immunol. Cell Biol. 2014, 92:304-313.
39. Thomas H.E., Irawaty W., Darwiche R., Brodnicki T.C., Santamaria P., Alison J., Key T.W. IL-1 receptor deficiency slow progression to diabetes in the NOD mouse. Diabetes 2004, 53:113-121.
40. Thomas H.E., Parker J.L., Schreiber R.D., Kay T.W. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J.Clin. Investig. 1998, 102:1249-1257.
41. Wang B., André I., Gonzalez A., Katz J.D., Aguet M., Benoist C., Mathis D. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13844-13849.
42. Wang X., Jiang L., Wallerman O., Engström U., Ameur A., Gupta R.K., Qi Y., Andersson L., Welsh N. Transcription factor ZBED6 affects gene expression, proliferation, and cell death in pancreatic beta cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:15997-16002.
43. Welsh N. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J.Biol. Chem. 1996, 271:8307-8312.
44. Welsh N., Cnop M., Kharroubi I., Bugliani M., Lupi R., Marchetti P., Eizirik D.L. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?. Diabetes 2005, 54:3238-3244.
45. Welsh N., Eizirik D.L., Bendtzen K., Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991, 129:3167-3173.
46. Welsh N., Margulis B., Borg L.A., Wiklund H.J., Saldeen J., Flodström M., Mello M.A., Andersson A., Pipeleers D.G., Hellerström C. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol. Med. 1995, 1:806-820.